ACTA1 Gene Nemaline Myopathy Type 3 Genetic Test

Genetic Testing

ACTA1 Gene Nemaline Myopathy Type 3 Genetic Test

KSh 56,000.00 Regular price
KSh 47,600.00 Current price
-15%

The ACTA1 Gene Nemaline Myopathy Type 3 NGS Genetic DNA Test is a crucial diagnostic tool for identifying genetic mutations associated with nemaline myopathy. Priced at 56,000 KSh, this test is essential for patients exhibiting symptoms of muscle weakness and neurological disorders. With a turnaround time of 3 to 4 weeks, patients can receive timely and accurate results, aiding in effective treatment planning.

What Is the ACTA1 Gene Nemaline Myopathy Type 3 Genetic Test?

The ACTA1 Gene Nemaline Myopathy Type 3 NGS Genetic DNA Test is a state-of-the-art diagnostic tool designed to identify mutations in the ACTA1 gene, which are responsible for nemaline myopathy. This genetic condition is characterized by muscle weakness and is considered a type of neurological disorder. Early and accurate diagnosis is crucial for effective management and treatment of the condition.

Who Should Consider This Test?

Individuals who exhibit symptoms such as:

  • Progressive muscle weakness
  • Difficulty in motor skills
  • Delayed motor milestones in children
  • Family history of nemaline myopathy or related muscular disorders

should consider undergoing this genetic test. Risk factors include a family history of genetic disorders and unexplained muscle weakness.

What Does the Test Detect or Measure?

This genetic test utilizes Next Generation Sequencing (NGS) technology to analyze the ACTA1 gene. It detects specific mutations that may lead to nemaline myopathy. By identifying these mutations, healthcare providers can better understand the underlying cause of muscle weakness in affected individuals.

What the Results May Show

Results from the ACTA1 Gene Nemaline Myopathy Type 3 NGS Genetic DNA Test will be provided within 3 to 4 weeks. A genetic counselor will help interpret the results and discuss the implications for treatment and family planning. It is essential to have a clinical history and a genetic counseling session prior to the test, which includes drawing a pedigree chart of family members affected by the disorder.

Benefits or Clinical Value

  • Accurate diagnosis of nemaline myopathy.
  • Informed treatment options based on genetic findings.
  • Assessment of risk for family members.
  • Guidance for future pregnancies in affected families.

Pricing

Test Name Current Price Regular Price
ACTA1 Gene Nemaline Myopathy Type 3 Genetic Test KSh 47,600.00 KSh 56,000.00

Book the ACTA1 Gene Nemaline Myopathy Type 3 Genetic Test

Contact Biopassion Diagnostics to confirm sample requirements and schedule this test.

SKU: 7f01c9397615 | Category: Genetic Testing